$KIDS
ORTHOPEDIATRICS CORP

2018 Q1 Form 10-K Financial Statement

#000142545018000040 Filed on March 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q3
Revenue $12.09M $11.68M $12.38M
YoY Change 23.89% 24.03% 22.1%
Cost Of Revenue $3.175M $8.832M $9.491M
YoY Change 35.28% 38.0% 32.61%
Gross Profit $8.919M $8.832M $9.491M
YoY Change 20.28% 192.64% 32.61%
Gross Profit Margin 73.75% 75.61% 76.69%
Selling, General & Admin $12.10M $12.10M $9.120M
YoY Change 59.89% 71.63% 27.04%
% of Gross Profit 135.62% 137.0% 96.09%
Research & Development $1.218M $940.0K $1.127M
YoY Change 77.29% 51.61% 124.95%
% of Gross Profit 13.66% 10.64% 11.87%
Depreciation & Amortization $681.0K $660.0K $660.0K
YoY Change 36.75% 32.0% 32.0%
% of Gross Profit 7.64% 7.47% 6.95%
Operating Expenses $13.31M $13.04M $10.25M
YoY Change 61.34% 70.01% 33.42%
Operating Profit -$4.395M -$4.204M -$754.0K
YoY Change 425.09% 29.27% 43.89%
Interest Expense -$550.0K -$630.0K $761.0K
YoY Change 22.22% 50.0% 90.73%
% of Operating Profit
Other Income/Expense, Net -$605.0K -$10.00K -$781.0K
YoY Change 35.04% -125.0% 142.55%
Pretax Income -$5.000M -$4.850M -$1.540M
YoY Change 287.6% 33.61% 81.18%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.000M -$4.845M -$1.536M
YoY Change 289.11% 33.36% 81.56%
Net Earnings / Revenue -41.34% -41.48% -12.41%
Basic Earnings Per Share
Diluted Earnings Per Share -$414.3K -$379.8K -$127.9K
COMMON SHARES
Basic Shares Outstanding 12.77M shares 12.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.60M $42.60M $2.200M
YoY Change 1341.67% 2562.5%
Cash & Equivalents $34.59M $42.58M $2.238M
Short-Term Investments
Other Short-Term Assets $1.100M $800.0K $1.900M
YoY Change 175.0% 300.0%
Inventory $23.40M $20.50M $19.00M
Prepaid Expenses
Receivables $6.838M $5.603M $5.686M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $65.95M $69.56M $28.89M
YoY Change 181.83% 234.01%
LONG-TERM ASSETS
Property, Plant & Equipment $12.28M $10.39M $9.749M
YoY Change 68.22% 20.94%
Goodwill
YoY Change
Intangibles $2.414M $2.349M $2.443M
YoY Change 86.72%
Long-Term Investments
YoY Change
Other Assets $1.600M
YoY Change 6.67%
Total Long-Term Assets $14.69M $12.74M $12.19M
YoY Change 41.29% 29.34%
TOTAL ASSETS
Total Short-Term Assets $65.95M $69.56M $28.89M
Total Long-Term Assets $14.69M $12.74M $12.19M
Total Assets $80.64M $82.30M $41.08M
YoY Change 138.59% 168.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.197M $5.495M $5.102M
YoY Change 26.26% 55.09%
Accrued Expenses $2.300M $2.900M $2.300M
YoY Change 35.29% 31.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $114.0K $113.0K $111.0K
YoY Change 14.0% 5.61%
Total Short-Term Liabilities $10.57M $9.467M $10.42M
YoY Change 20.11% 30.56%
LONG-TERM LIABILITIES
Long-Term Debt $25.32M $25.34M $27.50M
YoY Change 27.23% 45.37%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $25.32M $25.34M $27.50M
YoY Change 27.23% 45.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.57M $9.467M $10.42M
Total Long-Term Liabilities $25.32M $25.34M $27.50M
Total Liabilities $35.89M $34.81M $37.90M
YoY Change 25.05% 41.02%
SHAREHOLDERS EQUITY
Retained Earnings -$108.1M -$115.1M -$82.22M
YoY Change 47.3%
Common Stock $2.000K $2.000K $1.000K
YoY Change 100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.75M $47.50M -$72.49M
YoY Change
Total Liabilities & Shareholders Equity $80.64M $82.30M $41.08M
YoY Change 138.59% 168.29%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$5.000M -$4.845M -$1.536M
YoY Change 289.11% 33.36% 81.56%
Depreciation, Depletion And Amortization $681.0K $660.0K $660.0K
YoY Change 36.75% 32.0% 32.0%
Cash From Operating Activities -$5.033M -$3.330M $340.0K
YoY Change 100560.0% -352.27% -361.54%
INVESTING ACTIVITIES
Capital Expenditures $2.771M -$1.250M -$2.150M
YoY Change 108.03% -27.75% 76.23%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.930M -$1.250M -$2.150M
YoY Change 79.53% -27.75% 76.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $28.00K
YoY Change 7.69%
Cash From Financing Activities -$28.00K 44.92M 1.810M
YoY Change -101.13% 6317.14% 22.3%
NET CHANGE
Cash From Operating Activities -$5.033M -3.330M 340.0K
Cash From Investing Activities -$2.930M -1.250M -2.150M
Cash From Financing Activities -$28.00K 44.92M 1.810M
Net Change In Cash -$7.991M 40.34M 0.0000000002910
YoY Change -1054.72% 13810.34% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$5.033M -$3.330M $340.0K
Capital Expenditures $2.771M -$1.250M -$2.150M
Free Cash Flow -$7.804M -$2.080M $2.490M
YoY Change 483.69% -168.2% 128.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 kids Transfer Of Property And Equipment To Inventory
TransferOfPropertyAndEquipmentToInventory
1225000 USD
CY2017 kids Transfer Of Property And Equipment To Inventory
TransferOfPropertyAndEquipmentToInventory
1249000 USD
CY2017Q4 kids Classof Warrantor Right Exercised
ClassofWarrantorRightExercised
0 shares
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017Q2 dei Entity Public Float
EntityPublicFloat
0 USD
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001425450
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12770796 shares
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2017 kids Classof Warrantor Right Term
ClassofWarrantorRightTerm
P10Y
CY2015 kids Effective Income Tax Rate Reconciliation Change In Enacted State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedStateTaxRatePercent
0.038
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3543000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5495000 USD
CY2016 kids Effective Income Tax Rate Reconciliation Change In Enacted State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedStateTaxRatePercent
0.000
CY2017 kids Effective Income Tax Rate Reconciliation Change In Enacted State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedStateTaxRatePercent
0.000
CY2015 kids Increase Decreasein Research And Development Fee Obligation
IncreaseDecreaseinResearchAndDevelopmentFeeObligation
541000 USD
CY2016 kids Increase Decreasein Research And Development Fee Obligation
IncreaseDecreaseinResearchAndDevelopmentFeeObligation
628000 USD
CY2017 kids Increase Decreasein Research And Development Fee Obligation
IncreaseDecreaseinResearchAndDevelopmentFeeObligation
0 USD
CY2015 kids Initial Public Offering Costs
InitialPublicOfferingCosts
0 USD
CY2016 kids Initial Public Offering Costs
InitialPublicOfferingCosts
1979000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4098000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5603000 USD
CY2016Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1003000 USD
CY2017Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1304000 USD
CY2016Q4 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
1216000 USD
CY2017Q4 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
1601000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7217000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7943000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
135000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12824000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150424000 USD
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
990000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
4797000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
5876000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
4563000 USD
CY2015 us-gaap Advertising Expense
AdvertisingExpense
826000 USD
CY2016 us-gaap Advertising Expense
AdvertisingExpense
920000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
69561000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6581000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3878000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1609000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42582000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2703000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2269000 USD
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
40973000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00025
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2421599 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12621781 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2421599 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12621781 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2017 dei Entity Registrant Name
EntityRegistrantName
ORTHOPEDIATRICS CORP
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016Q4 kids Classof Warrantor Right Exercised
ClassofWarrantorRightExercised
0 shares
CY2017 kids Initial Public Offering Costs
InitialPublicOfferingCosts
0 USD
CY2017 kids Number Of Related Party Entities Suppliers
NumberOfRelatedPartyEntitiesSuppliers
2 supplier
CY2015 kids Research And Development Fee Obligation Termination
ResearchAndDevelopmentFeeObligationTermination
0 USD
CY2016 kids Research And Development Fee Obligation Termination
ResearchAndDevelopmentFeeObligationTermination
889000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7891000 USD
CY2017Q4 kids Operating Loss Carryforwards Limitationson Use Estimated Amount Subjectto Limitation
OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjecttoLimitation
16200000 USD
CY2017Q4 kids Operating Loss Carryforwards Limitationson Use Estimated Amount Subjectto Limitation Annual Limit
OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjecttoLimitationAnnualLimit
1062000 USD
CY2017Q4 kids Operating Loss Carryforwards Limitationson Use Estimated Amount Subjectto Limitation Annual Limit Increase
OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjecttoLimitationAnnualLimitIncrease
2302000 USD
CY2017 kids Redeemable Preferred Stock Liquidation Preference Payment
RedeemablePreferredStockLiquidationPreferencePayment
0 USD
CY2017 kids Research And Development Fee Obligation Termination
ResearchAndDevelopmentFeeObligationTermination
0 USD
CY2017 kids Researchand Development Arrangement Contractto Performfor Others Minimum Annual Royalty Payment
ResearchandDevelopmentArrangementContracttoPerformforOthersMinimumAnnualRoyaltyPayment
500000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6572000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8797000 USD
CY2017 kids Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
11095000 USD
CY2015 kids Transfer Of Property And Equipment To Inventory
TransferOfPropertyAndEquipmentToInventory
474000 USD
CY2017Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
CY2017 us-gaap Advertising Expense
AdvertisingExpense
1128000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
152000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
143000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6000 USD
CY2017Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
9367000 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
5984000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
246000 USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00025
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4536100 shares
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4619018 shares
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
769065 shares
CY2016Q4 us-gaap Assets
Assets
30676000 USD
CY2017Q4 us-gaap Assets
Assets
82301000 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
6826000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
20826000 USD
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.38
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.03
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
7157000 USD
CY2016Q4 us-gaap Cost Of Revenue
CostOfRevenue
6400000 USD
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.14
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.55
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.56
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
7415000 USD
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
10931000 USD
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.70
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.41
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.86
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.375
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.098
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
8712000 USD
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
9491000 USD
CY2017Q4 us-gaap Cost Of Revenue
CostOfRevenue
8832000 USD
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
11170000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
8494000 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3184000 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2562000 USD
CY2015 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
8363000 USD
CY2016 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-3661000 USD
CY2017 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-2887000 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
62000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
244000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-131000 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-477000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-325000 USD
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
117000 USD
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
216000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21284000 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29830000 USD
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1168000 USD
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1167000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
62000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
244000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18523000 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26091000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
105000 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
113000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
336000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
305000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1035000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1938000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21222000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29586000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
62000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
244000 USD
CY2015 us-gaap Depreciation
Depreciation
1848000 USD
CY2016 us-gaap Depreciation
Depreciation
1867000 USD
CY2017 us-gaap Depreciation
Depreciation
2159000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1854000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1902000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2405000 USD
CY2015 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-38000 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.27
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.002
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-1.222
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2219000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2905000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
2219000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
2905000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
76000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
323000 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.76
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.97
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.936
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.259
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
438000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
383000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
219000 USD
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.122
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.007
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.041
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.042
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1074000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
302000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
359000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
388000 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
598000 USD
CY2016 us-gaap Gross Profit
GrossProfit
26367000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2412000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
998000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2089000 USD
CY2016 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P12Y8M12D
CY2017 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P11Y8M12D
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-38000 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11407000 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11631000 USD
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16972000 USD
CY2015 us-gaap Gross Profit
GrossProfit
21637000 USD
CY2017 us-gaap Gross Profit
GrossProfit
34450000 USD
CY2015 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2015 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2016 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2017 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2015 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7853000 USD
CY2016 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6572000 USD
CY2017 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8932000 USD
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-38000 USD
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
1047000 USD
CY2016 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
280000 USD
CY2017 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
1505000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1354000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1544000 USD
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1952000 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
810000 USD
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1675000 USD
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
258000 USD
CY2015 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
0 USD
CY2016 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
0 USD
CY2017 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-135000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-30000 USD
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11000 USD
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
260000 USD
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
260000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1258000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2349000 USD
CY2015 us-gaap Interest Expense
InterestExpense
1230000 USD
CY2016 us-gaap Interest Expense
InterestExpense
1476000 USD
CY2017 us-gaap Interest Expense
InterestExpense
2490000 USD
CY2015 us-gaap Interest Paid
InterestPaid
1230000 USD
CY2016 us-gaap Interest Paid
InterestPaid
1476000 USD
CY2017 us-gaap Interest Paid
InterestPaid
2490000 USD
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
341000 USD
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
219000 USD
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
344000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
24682000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
34806000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30676000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82301000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7251000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9467000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
17538000 USD
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
25452000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
107000 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
113000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
24829000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
113000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
137000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
131000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
124000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
118000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
17431000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25339000 USD
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4500000 USD
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
3921000 USD
CY2016Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
12931000 USD
CY2017Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
21418000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-98000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3604000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54734000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1713000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4754000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6544000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-892000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1119000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7217000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-7891000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1805000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-288000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-846000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1285000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1266000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-1536000 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-4845000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1486000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-3633000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-6572000 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2711000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-865000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-524000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3252000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-6127000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-837000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-677000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-754000 USD
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4204000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-6472000 USD
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
70335000 USD
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2720000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-8932000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12688000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3066000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1688000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2405000 USD
CY2016Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5289000 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12448000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3021000 USD
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15078000 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23530000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1261000 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-445000 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2460000 USD
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2015 us-gaap Operating Expenses
OperatingExpenses
28229000 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
32494000 USD
CY2017 us-gaap Operating Expenses
OperatingExpenses
40922000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-6592000 USD
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
135000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
135000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1382000 USD
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
954000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1031000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 USD
CY2015 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2016 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
5965000 USD
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2016 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
794000 USD
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
990000 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
41000 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
406000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2211000 USD
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1337000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4348000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5207000 USD
CY2017 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
831000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
233000 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
78000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1789000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2223000 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53775000 USD
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3423000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78134000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-103066000 USD
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4500000 USD
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7992000 USD
CY2015 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
539000 USD
CY2015 us-gaap Revenues
Revenues
31004000 USD
CY2016Q1 us-gaap Revenues
Revenues
8071000 USD
CY2016Q2 us-gaap Revenues
Revenues
9674000 USD
CY2016 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2017 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15809000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18334000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8592000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10391000 USD
CY2015 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
CY2016 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
CY2017 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
16000000 USD
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
98000 USD
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
102000 USD
CY2016Q3 us-gaap Revenues
Revenues
10135000 USD
CY2016Q4 us-gaap Revenues
Revenues
9418000 USD
CY2016 us-gaap Revenues
Revenues
37298000 USD
CY2017Q1 us-gaap Revenues
Revenues
9762000 USD
CY2017Q2 us-gaap Revenues
Revenues
11802000 USD
CY2017Q3 us-gaap Revenues
Revenues
12375000 USD
CY2017Q4 us-gaap Revenues
Revenues
11681000 USD
CY2017 us-gaap Revenues
Revenues
45620000 USD
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15033000 USD
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16661000 USD
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20527000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1229000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1251000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3478000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2015 us-gaap Shipping And Handling Revenue
ShippingAndHandlingRevenue
279000 USD
CY2016 us-gaap Shipping And Handling Revenue
ShippingAndHandlingRevenue
320000 USD
CY2017 us-gaap Shipping And Handling Revenue
ShippingAndHandlingRevenue
336000 USD
CY2015 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
1454000 USD
CY2016 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
1502000 USD
CY2017 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
1783000 USD
CY2017 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
54997000 USD
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53775000 USD
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1229000 USD
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1251000 USD
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
3478000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-42653000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-54112000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-65309000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
47495000 USD
CY2017Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
335000 USD
CY2015 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4797000 USD
CY2016 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
5876000 USD
CY2017 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4563000 USD
CY2015 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
4797000 USD
CY2016 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
5876000 USD
CY2017 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
4563000 USD
CY2016Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
71303000 USD
CY2017Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2016Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
7000000 shares
CY2016Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
5446978 shares
CY2017Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2017Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
500000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-8363000 USD
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3661000 USD
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2887000 USD
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1744356 shares
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1744356 shares
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4017330 shares
CY2017 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">BUSINESS </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">OrthoPediatrics Corp., a Delaware Corporation, is a medical device company committed to designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers the ability to treat children with technologies specifically designed to meet their needs. We sell our specialized products, including PediLoc</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:Arial;font-size:8pt;">, PediPlates</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:Arial;font-size:8pt;">, Cannulated Screws, PediFlex</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">TM</sup></font><font style="font-family:Arial;font-size:8pt;"> nail, PediNail</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">TM</sup></font><font style="font-family:Arial;font-size:8pt;">, PediLoc</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:Arial;font-size:8pt;"> Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, Bandloc and Pediguard, to various hospitals and medical facilities throughout the United States and various international markets. We currently use a contract manufacturing model for the manufacturing of implants and related surgical instrumentation. </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">In early 2017, we expanded operations and established legal entities in the United Kingdom, Australia and New Zealand permitting us to sell under an agency model direct to local hospitals in these countries. Operations began in the United Kingdom on April 3, 2017, in Australia on May 1, 2017 and in New Zealand on July 1, 2017. </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Our controlling investor is Squadron Capital (&#8220;Squadron&#8221;), a private equity firm headquartered near Hartford, Connecticut.</font></div></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Preparation of our consolidated financial statements requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as of the date of the consolidated financial statements. By their nature, these judgments are subject to an inherent degree of uncertainty. We use historical experience and other assumptions as the basis for our judgments and estimates. Because future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Any changes in these estimates will be reflected in our consolidated financial statements.</font></div></div>

Files In Submission

Name View Source Status
0001425450-18-000040-index-headers.html Edgar Link pending
0001425450-18-000040-index.html Edgar Link pending
0001425450-18-000040.txt Edgar Link pending
0001425450-18-000040-xbrl.zip Edgar Link pending
a19158663v1_exhibit24-poa.htm Edgar Link pending
chart-465878c81a338311429.jpg Edgar Link pending
deloitteconsent-10kfiling.htm Edgar Link pending
exhbit322-cfocertification.htm Edgar Link pending
exhibit311-ceocertification.htm Edgar Link pending
exhibit312-cfocertification.htm Edgar Link pending
exhibit321-ceocertification.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kids-20171231.xml Edgar Link completed
kids-20171231.xsd Edgar Link pending
kids-20171231_cal.xml Edgar Link unprocessable
kids-20171231_def.xml Edgar Link unprocessable
kids-20171231_lab.xml Edgar Link unprocessable
kids-20171231_pre.xml Edgar Link unprocessable
orthopediatrics10-k2017.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
subsidiariesoforthopediatr.htm Edgar Link pending